The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†
Open accessAbstract
In this study, we investigated the role of acyl-coenzyme A:diacylglycerol acyltransferase 2 (DGAT2) in glucose and lipid metabolism in obese mice by reducing its expression in liver and fat with an optimized antisense oligonucleotide (ASO). High-fat diet-induced obese (DIO) C57BL/6J mice and ob/ob mice were treated with DGAT2 ASO, control ASO, or saline. DGAT2 ASO treatment reduced DGAT2 messenger RNA (mRNA) levels by more than 75% in both liver and fat but did not change DGAT1 mRNA levels in either of these tissues, which resulted in decreased DGAT activity in liver but not in fat. DGAT2 ASO treatment did not cause significant changes in body weight, adiposity, metabolic rate, insulin sensitivity, or skin microstructure. However, DGAT2 ASO treatment caused a marked reduction in hepatic triglyceride content and improved hepatic steatosis in both models, which was consistent with a dramatic decrease in triglyceride synthesis and an increase in fatty acid oxidation observed in primary mouse hepatocytes treated with DGAT2 ASO. In addition, the treatment lowered hepatic triglyceride secretion rate and plasma triglyceride levels, and improved plasma lipoprotein profile in DIO mice. The positive effects of the DGAT2 ASO were accompanied by a reduction in the mRNA levels of several hepatic lipogenic genes, including SCD1, FAS, ACC1, ACC2, ATP-citrate lyase, glycerol kinase, and HMG-CoA reductase. In conclusion, reduction of DGAT2 expression in obese animals can reduce hepatic lipogenesis and hepatic steatosis as well as attenuate hyperlipidemia, thereby leading to an improvement in metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Skeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Cases, S., Smith, S. J., Zheng, Y.-W., Myers, H. M., Lear, S. R., Sande, E., Novak, S., Collins, C., Welch, C. B., Lusis, A. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13018 · Cited by 1,123
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat
Smith, S. J., Cases, S., Jensen, D. R., Chen, H. C., Sande, E., Tow, B., Sanan, D. A., Raber, J., Eckel, R. H., & Farese, R. V. (2000) · Nature Genetics · doi:10.1038/75651 · Cited by 896
Cloning of DGAT2, a Second Mammalian Diacylglycerol Acyltransferase, and Related Family Members
Cases, S., Stone, S. J., Zhou, P., Yen, E., Tow, B., Lardizabal, K. D., Voelker, T., & Farese, R. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106219200 · Cited by 818
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice
Stone, S. J., Myers, H. M., Watkins, S. M., Brown, B. E., Feingold, K. R., Elias, P. M., & Farese, R. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311000200 · Cited by 598
Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
Mechanisms of Liver and Muscle Insulin Resistance Induced by Chronic High-Fat Feeding
Oakes, N. D., Cooney, G. J., Camilleri, S., Chisholm, D. J., & Kraegen, E. W. (1997) · Diabetes · doi:10.2337/diab.46.11.1768 · Cited by 414
Magaña, M. M., & Osborne, T. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32689 · Cited by 336
Insulin resistance in type 2 diabetes: role of fatty acids
Arner, P. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.254 · Cited by 323
Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1
Chen, H. C., Smith, S. J., Ladha, Z., Jensen, D. R., Ferreira, L. D., Pulawa, L. K., McGuire, J. G., Pitas, R. E., Eckel, R. H., & Farese, R. V. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214672 · Cited by 266
AZZOUT-MARNICHE, D., BÉCARD, D., GUICHARD, C., FORETZ, M., FERRÉ, P., & FOUFELLE, F. (2000) · Biochemical Journal · doi:10.1042/bj3500389 · Cited by 257
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1
Jiang, G., Li, Z., Liu, F., Ellsworth, K. P., Dallas-Yang, Q., Wu, M. S., Ronan, J., Esau, C., Murphy, C., Szalkowski, D., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23962 · Cited by 255
Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1
Jiang, G., Li, Z., Liu, F., Ellsworth, K., Dallas-Yang, Q., Wu, M., Ronan, J., Esau, C., Murphy, C., Szalkowski, D., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523962 · Cited by 241
Murase, T., Mizuno, T., Omachi, T., Onizawa, K., Komine, Y., Kondo, H., Hase, T., & Tokimitsu, I. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31661-8 · Cited by 239
Crooke, R. M., Graham, M. J., Lemonidis, K. M., Whipple, C. P., Koo, S., & Perera, R. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400492-jlr200 · Cited by 225
Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance
Adeli, K., Taghibiglou, C., Van Iderstine, S. C., & Lewis, G. F. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00084-6 · Cited by 194
Akiyama, T., Tachibana, I., Shirohara, H., Watanabe, N., & Otsuki, M. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01205-3 · Cited by 183
Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase
Farese, R. V., Cases, S., & Smith, S. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00002 · Cited by 154
Matsumoto, M., Ogawa, W., Teshigawara, K., Inoue, H., Miyake, K., Sakaue, H., & Kasuga, M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1672 · Cited by 140
Bené, H., Lasky, D., & Ntambi, J. M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5102 · Cited by 132
Influence of Plasma Free Fatty Acids on Lipoprotein Synthesis and Diabetic Dyslipidemia
Julius, U. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-41284 · Cited by 131
Guillet-Deniau, I., Mieulet, V., Lay, S. L., Achouri, Y., Carré, D., Girard, J. R., Foufelle, F., & Ferré, P. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1722 · Cited by 129
Magana, M. M., Lin, S. S., Dooley, K. A., & Osborne, T. F. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37181-9 · Cited by 125
High Dietary Fat Promotes Syndrome X in Nonobese Rats
Axen, K. V., Dikeakos, A., & Sclafani, A. J. (2003) · Journal of Nutrition · doi:10.1093/jn/133.7.2244 · Cited by 86
Chen, M.-T., Kaufman, L. N., Spennetta, T., & Shrago, E. (1992) · Metabolism · doi:10.1016/0026-0495(92)90221-u · Cited by 83
Phenotypic Correction of Diabetic Mice by Adenovirus-Mediated Glucokinase Expression
Desai, U. J., Slosberg, E. D., Boettcher, B. R., Caplan, S. L., Fanelli, B., Stephan, Z. F., Gunther, V., Kaleko, M., & Connelly, S. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2287 · Cited by 61
Isolation of Rat Liver Hepatocytes
Neufeld, D. S. (2003) · Humana Press eBooks · doi:10.1385/0-89603-441-0:145 · Cited by 60
Emilsson, V., O’Dowd, J. F., Wang, S., Liu, Y.-L., Sennitt, M. V., Heyman, R. A., & Cawthorne, M. A. (2000) · Metabolism · doi:10.1053/meta.2000.18692 · Cited by 50
Yu, X. X., Drackley, J. K., & Odle, J. (1997) · Journal of Nutrition · doi:10.1093/jn/127.9.1814 · Cited by 43
Self-citationReduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor
Metzger, S., Hassin, T., Barash, V., Pappo, O., & Chajek‐Shaul, T. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.5.e957 · Cited by 36
Insulin‐sensitizing action of rosiglitazone is enhanced by preventing hyperphagia
Pickavance, L. C., Buckingham, R. E., & Wilding, J. P. H. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00120.x · Cited by 25
Cited by
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Self-citationSteinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Metadata
- Authors
- Yu, X. X., Murray, S. F., Pandey, S. K., Booten, S. L., Bao, D., Song, X., Kelly, S., Chen, S., McKay, R., Monia, B. P., & Bhanot, S.
- Venue
- Hepatology
- Published
- 2005-08
- Volume
- 42
- Issue
- 2
- Pages
- 362-371
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2169894356
- Cited by
- 301
- References
- 34
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.